NIRMAN AGRI GENETICS
Back to Balance Sheet
|
NIRMAN AGRI GENETICS Last 5 Year Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of NIRMAN AGRI GENETICS ?
| Year | Current Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Current Liabilities of NIRMAN AGRI GENETICS Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Current Liabilities of peers of NIRMAN AGRI GENETICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NIRMAN AGRI GENETICS | ₹39.4 Cr | -1.5% | -7.4% | -80.7% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹11,463.5 Cr | -6.9% | -2% | -6.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,850.2 Cr | -6.6% | -15.6% | -21.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,834.0 Cr | -4.8% | -13.9% | -19.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹888.5 Cr | -6.9% | -4.5% | -38.6% | Stock Analytics | |
| INDO US BIOTECH | ₹282.2 Cr | -2.4% | 17.2% | -34.9% | Stock Analytics | |
NIRMAN AGRI GENETICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NIRMAN AGRI GENETICS | -1.5% |
-7.4% |
-80.7% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses